Literature DB >> 17003487

Down-regulation of ubiquitin ligase Cbl induced by twist haploinsufficiency in Saethre-Chotzen syndrome results in increased PI3K/Akt signaling and osteoblast proliferation.

Hind Guenou1, Karim Kaabeche, Cécilie Dufour, Hichem Miraoui, Pierre J Marie.   

Abstract

Genetic mutations of Twist, a basic helix-loop-helix transcription factor, induce premature fusion of cranial sutures in Saethre-Chotzen syndrome (SCS). We report here a previously undescribed mechanism involved in the altered osteoblastogenesis in SCS. Cranial osteoblasts from an SCS patient with a Twist mutation causing basic helix-loop-helix deletion exhibited decreased expression of E3 ubiquitin ligase Cbl compared with wild-type osteoblasts. This was associated with decreased ubiquitin-mediated degradation of phosphatidyl inositol 3 kinase (PI3K) and increased PI3K expression and PI3K/Akt signaling. Increased PI3K immunoreactivity was also found in osteoblasts in histological sections of affected cranial sutures from SCS patients. Transfection with Twist or Cbl abolished the increased PI3K/Akt signaling in Twist mutant osteoblasts. Forced overexpression of Cbl did not correct the altered expression of osteoblast differentiation markers in Twist mutant cells. In contrast, pharmacological inhibition of PI3K/Akt, but not ERK signaling, corrected the increased cell growth in Twist mutant osteoblasts. The results show that Twist haploinsufficiency results in decreased Cbl-mediated PI3K degradation in osteoblasts, causing PI3K accumulation and activation of PI3K/Akt-dependent osteoblast growth. This provides genetic and biochemical evidence for a role for Cbl-mediated PI3K signaling in the altered osteoblast phenotype induced by Twist haploinsufficiency in SCS.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17003487      PMCID: PMC1698848          DOI: 10.2353/ajpath.2006.060102

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  50 in total

Review 1.  PI 3-kinase, Akt and cell survival.

Authors:  Julian Downward
Journal:  Semin Cell Dev Biol       Date:  2004-04       Impact factor: 7.727

Review 2.  The ubiquitin-proteasome pathway.

Authors:  Pia Roos-Mattjus; Lea Sistonen
Journal:  Ann Med       Date:  2004       Impact factor: 4.709

3.  ATF4 is a substrate of RSK2 and an essential regulator of osteoblast biology; implication for Coffin-Lowry Syndrome.

Authors:  Xiangli Yang; Koichi Matsuda; Peter Bialek; Sylvie Jacquot; Howard C Masuoka; Thorsten Schinke; Lingzhen Li; Stefano Brancorsini; Paolo Sassone-Corsi; Tim M Townes; Andre Hanauer; Gerard Karsenty
Journal:  Cell       Date:  2004-04-30       Impact factor: 41.582

4.  Fibroblast growth factor-2 induces osteoblast survival through a phosphatidylinositol 3-kinase-dependent, -beta-catenin-independent signaling pathway.

Authors:  F Debiais; G Lefèvre; J Lemonnier; S Le Mée; F Lasmoles; F Mascarelli; P J Marie
Journal:  Exp Cell Res       Date:  2004-07-01       Impact factor: 3.905

Review 5.  The expanding role of PI3-kinase in bone.

Authors:  Lauren H Golden; Karl L Insogna
Journal:  Bone       Date:  2004-01       Impact factor: 4.398

6.  Smurf1 inhibits osteoblast differentiation and bone formation in vitro and in vivo.

Authors:  Ming Zhao; Mei Qiao; Stephen E Harris; Babatunde O Oyajobi; Gregory R Mundy; Di Chen
Journal:  J Biol Chem       Date:  2003-12-29       Impact factor: 5.157

7.  Requirement of BMP-2-induced phosphatidylinositol 3-kinase and Akt serine/threonine kinase in osteoblast differentiation and Smad-dependent BMP-2 gene transcription.

Authors:  Nandini Ghosh-Choudhury; Sherry L Abboud; Riko Nishimura; Anthony Celeste; Lenin Mahimainathan; Goutam Ghosh Choudhury
Journal:  J Biol Chem       Date:  2002-06-25       Impact factor: 5.157

8.  TWIST inactivation reduces CBFA1/RUNX2 expression and DNA binding to the osteocalcin promoter in osteoblasts.

Authors:  Malika Yousfi; Françoise Lasmoles; Pierre J Marie
Journal:  Biochem Biophys Res Commun       Date:  2002-09-27       Impact factor: 3.575

9.  A twist code determines the onset of osteoblast differentiation.

Authors:  Peter Bialek; Britt Kern; Xiangli Yang; Marijke Schrock; Drazen Sosic; Nancy Hong; Hua Wu; Kai Yu; David M Ornitz; Eric N Olson; Monica J Justice; Gerard Karsenty
Journal:  Dev Cell       Date:  2004-03       Impact factor: 12.270

10.  Proteasomal degradation of Runx2 shortens parathyroid hormone-induced anti-apoptotic signaling in osteoblasts. A putative explanation for why intermittent administration is needed for bone anabolism.

Authors:  Teresita Bellido; A Afshan Ali; Lilian I Plotkin; Qiang Fu; Igor Gubrij; Paula K Roberson; Robert S Weinstein; Charles A O'Brien; Stavros C Manolagas; Robert L Jilka
Journal:  J Biol Chem       Date:  2003-10-01       Impact factor: 5.157

View more
  17 in total

Review 1.  Directing traffic in neural cells: determinants of receptor tyrosine kinase localization and cellular responses.

Authors:  Robert J Romanelli; Teresa L Wood
Journal:  J Neurochem       Date:  2008-06-01       Impact factor: 5.372

Review 2.  Degradation of activated protein kinases by ubiquitination.

Authors:  Zhimin Lu; Tony Hunter
Journal:  Annu Rev Biochem       Date:  2009       Impact factor: 23.643

Review 3.  Concerted stimuli regulating osteo-chondral differentiation from stem cells: phenotype acquisition regulated by microRNAs.

Authors:  Jan O Gordeladze; Farida Djouad; Jean-Marc Brondello; Daniele Noël; Isabelle Duroux-Richard; Florence Apparailly; Christian Jorgensen
Journal:  Acta Pharmacol Sin       Date:  2009-10       Impact factor: 6.150

4.  Loss of Cbl-PI3K interaction modulates the periosteal response to fracture by enhancing osteogenic commitment and differentiation.

Authors:  Vanessa Scanlon; Bhavita Walia; Jungeun Yu; Marc Hansen; Hicham Drissi; Peter Maye; Archana Sanjay
Journal:  Bone       Date:  2016-11-22       Impact factor: 4.398

5.  The Casitas B lineage lymphoma (Cbl) mutant G306E enhances osteogenic differentiation in human mesenchymal stromal cells in part by decreased Cbl-mediated platelet-derived growth factor receptor alpha and fibroblast growth factor receptor 2 ubiquitination.

Authors:  Nicolas Sévère; Hichem Miraoui; Pierre J Marie
Journal:  J Biol Chem       Date:  2011-05-19       Impact factor: 5.157

6.  Loss of Cbl-PI3K interaction enhances osteoclast survival due to p21-Ras mediated PI3K activation independent of Cbl-b.

Authors:  Naga Suresh Adapala; Mary F Barbe; Alexander Y Tsygankov; Joseph A Lorenzo; Archana Sanjay
Journal:  J Cell Biochem       Date:  2014-07       Impact factor: 4.429

7.  MAPK/ERK Signaling Pathway Analysis in Primary Osteoblasts From Patients With Nonsyndromic Sagittal Craniosynostosis.

Authors:  Sun-Don Kim; Garima Yagnik; Michael L Cunningham; Jinoh Kim; Simeon A Boyadjiev
Journal:  Cleft Palate Craniofac J       Date:  2013-04-08

8.  A specific role for phosphoinositide 3-kinase and AKT in osteoblasts?

Authors:  Imelda M McGonnell; Agamemnon E Grigoriadis; Eric W-F Lam; Joanna S Price; Andrew Sunters
Journal:  Front Endocrinol (Lausanne)       Date:  2012-07-20       Impact factor: 5.555

9.  Peroxisome proliferator-activated receptor gamma and regulations by the ubiquitin-proteasome system in pancreatic cancer.

Authors:  Athina Stravodimou; Gianluigi Mazzoccoli; Ioannis A Voutsadakis
Journal:  PPAR Res       Date:  2012-09-19       Impact factor: 4.964

Review 10.  E3 ubiquitin ligase-mediated regulation of bone formation and tumorigenesis.

Authors:  N Sévère; F-X Dieudonné; P J Marie
Journal:  Cell Death Dis       Date:  2013-01-17       Impact factor: 8.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.